Worth reading
78Important
Scored from 4 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
5
Yen per share (projected increase in annual dividend)Wording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportFiscal year ended March 2026 (39th fiscal year)10 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales11,533 million yen+105.2%
Operating profit634 million yen+96.2%
Ordinary income826 million yen+121.7%
Net income464 million yen+114.3%
Selling, general and administrative expenses1,145 million yen
Full-year earnings forecast
Fiscal Period CoveredFiscal year ending March 2027
Net Sales
12,125 million yen
Operating profit
740 million yen
Ordinary income
751 million yen
Profit attributable to owners of the parent
508 million yen
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
The earnings plan was achieved, but net income fell short of the plan due to the recognition of an impairment lossBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Higher sales of assistive products and at existing branches206 million yen
- Higher sales from M&A (business acquisitions)181 million yen
- Higher sales from new group homes95 million yen
- Bonuses funded by subsidies under the Subsidy Program for Securing Nursing-Care Personnel and Improving Workplaces and Other Initiatives30 million yen
- Construction subsidy income from the opening of new nursing-care facilities61 million yen
- Subsidy income under the Subsidy Program for Securing Nursing-Care Personnel and Improving Workplaces and Other Initiatives30 million yen
- Projected increase in operating profit in the assistive-products business for the fiscal year ending March 202711 million yen
- Projected increase in operating profit in the nursing-care business for the fiscal year ending March 202794 million yen
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Higher crude oil and other prices due to heightened tensions in the Middle East, rising prices and construction costs, maintenance of a high in-house rental procurement ratio, and the loss of subsidy incomeNew initiatives
- M&A of 2 assistive-products branches (business acquisitions)
- Conversion of 1 existing nursing-care facility into a group home through renovation
- Making M&A of companies in the same industry a priority growth initiative
- Withdrawal from the intensive home-visit care business
Segment results
- Assistive-products businessNet Sales4,974 million yenOperating profit320 million yen
- Nursing Care BusinessNet Sales6,559 million yenOperating profit313 million yen
Medium-term management plan targets
Reassess the nursing-care business by returning to the fundamentals of care and resume the growth trajectory. Aim to achieve the plan with a focus on M&A of companies in the same industry. Target figures are Not disclosed.Financial targets
A target equity ratio of approximately 50%. The actual ratio at the end of the fiscal year ended March 2026 was 42.1%.Number of stores and locations
Acquired 2 assistive-products branches through M&A and opened 1 new nursing-care facility (group home). The Company withdrew from intensive home-visit care during the fiscal year. For the fiscal year ending March 2027, the Company plans to renovate 1 existing nursing-care facility and convert it into a group home.Annual Dividend
Actual for the fiscal year ended March 2026: ¥38 (interim ¥13, year-end ¥25); forecast for the fiscal year ending March 2027: ¥43 (interim ¥18, year-end ¥25)Payout ratio
Actual for the fiscal year ended March 2026: 20.3%; forecast for the fiscal year ending March 2027: 20.6%. While the equity ratio remains below 50%, the Company aims for a consolidated dividend payout ratio of 25%.| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Fiscal year ended March 2026 (39th fiscal year) |
| Net Sales | 11,533 million yen (YoY +105.2%) |
| Operating profit | 634 million yen (YoY +96.2%) |
| Ordinary income | 826 million yen (YoY +121.7%) |
| Net income | 464 million yen (YoY +114.3%) |
| Selling, general and administrative expenses | 1,145 million yen |
| Full-year earnings forecast | Fiscal Period Covered Fiscal year ending March 2027 / Net Sales 12,125 million yen / Operating profit 740 million yen / Ordinary income 751 million yen / Profit attributable to owners of the parent 508 million yen |
| Self-assessment against the plan | The earnings plan was achieved, but net income fell short of the plan due to the recognition of an impairment loss |
| Segment results | Segment Assistive-products business / Net Sales 4,974 million yen / Operating profit 320 million yen / Year on year Not disclosed, Segment Nursing Care Business / Net Sales 6,559 million yen / Operating profit 313 million yen / Year on year Not disclosed |
| Breakdown of Factors Affecting the Change | Item Higher sales of assistive products and at existing branches / Amount 206 million yen, Item Higher sales from M&A (business acquisitions) / Amount 181 million yen, Item Higher sales from new group homes / Amount 95 million yen, Item Bonuses funded by subsidies under the Subsidy Program for Securing Nursing-Care Personnel and Improving Workplaces and Other Initiatives / Amount 30 million yen, Item Construction subsidy income from the opening of new nursing-care facilities / Amount 61 million yen, Item Subsidy income under the Subsidy Program for Securing Nursing-Care Personnel and Improving Workplaces and Other Initiatives / Amount 30 million yen, Item Projected increase in operating profit in the assistive-products business for the fiscal year ending March 2027 / Amount 11 million yen, Item Projected increase in operating profit in the nursing-care business for the fiscal year ending March 2027 / Amount 94 million yen |
| Number of stores and locations | Acquired 2 assistive-products branches through M&A and opened 1 new nursing-care facility (group home). The Company withdrew from intensive home-visit care during the fiscal year. For the fiscal year ending March 2027, the Company plans to renovate 1 existing nursing-care facility and convert it into a group home. |
| Assumptions Underlying the Business Outlook | Higher crude oil and other prices due to heightened tensions in the Middle East, rising prices and construction costs, maintenance of a high in-house rental procurement ratio, and the loss of subsidy income |
| Medium-term management plan targets | Reassess the nursing-care business by returning to the fundamentals of care and resume the growth trajectory. Aim to achieve the plan with a focus on M&A of companies in the same industry. Target figures are Not disclosed. |
| Financial targets | A target equity ratio of approximately 50%. The actual ratio at the end of the fiscal year ended March 2026 was 42.1%. |
| Annual Dividend | Actual for the fiscal year ended March 2026: ¥38 (interim ¥13, year-end ¥25); forecast for the fiscal year ending March 2027: ¥43 (interim ¥18, year-end ¥25) |
| Payout ratio | Actual for the fiscal year ended March 2026: 20.3%; forecast for the fiscal year ending March 2027: 20.6%. While the equity ratio remains below 50%, the Company aims for a consolidated dividend payout ratio of 25%. |
| New initiatives | M&A of 2 assistive-products branches (business acquisitions), Conversion of 1 existing nursing-care facility into a group home through renovation, Making M&A of companies in the same industry a priority growth initiative, Withdrawal from the intensive home-visit care business |
Items this document does not state (13)
Gross Profit MarginOperating profit marginResults for the three months of the current quarterProgress against full-year forecastKey KPIsUnit price and quantity metricsNumber of employeesRisk amount incorporated into the outlookAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, net sales increased due to the acquisition of 2 assistive-products branches, the opening of 1 group home and stronger sales efforts at existing facilities. Ordinary profit increased as a result of higher sales and subsidy income, while operating profit was affected by new-opening costs, higher prices, personnel-related expenses and bonuses. Net income increased due to higher ordinary profit despite the recognition of an impairment loss. For the fiscal year ending March 2027, the Company expects operating profit to increase on the effects of higher sales and improvements in business operations, while ordinary profit is expected to decline as subsidy income falls away and net income is expected to increase as the impairment loss falls away.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.